Log In
Print
BCIQ
Print
Print this Print this
 

Intercept Blood System for plasma

Also known as: amotosalen (formerly Intercept Plasma System (S-59))

  Manage Alerts
Collapse Summary General Information
Company Cerus Corp.
DescriptionPlasma pathogen inactivation system using amotosalen light-activated compound
Molecular Target DNA ; RNA
Mechanism of ActionPhotodynamic therapy
Therapeutic ModalityMedical Devices: Photodynamic therapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today